Bank of Papua New Guinea Goes Live With Misys Opics Plus, Opics Risk Plus and Eagleye

Misys (LSE: MSY), the global application software and services company,
today announced that Bank of Papua New Guinea has gone live with Misys Opics
Plus v3.0, Misys Opics Risk Plus and Misys

Eagleye. The integrated solution
will deliver enhanced efficiency and visibility in its reserves management
operation and increased automation and management control of credit, market
and operational risks.

The Bank of Papua New Guinea is a contemporary central bank and
regulator, employing best practice in the development of monetary policy,
financial sector supervision and payment system. The Bank's objective was to
significantly update its systems in order to improve its operational
efficiency and risk management capabilities to ensure it had a comprehensive
reserves management system.

The Bank selected Misys following a three-way competitive pitch, which
saw the Misys solutions emerging as the clear leader in providing operational
efficiency with effective risk management solutions. The latest version of
Misys Opics Plus will enable the Bank to process higher volumes of treasury
instruments and provide clients with more products. The back office will
utilise the system's event-based workflow manager to confirm deal and payment
information with counterparties and send automatically generated
confirmations.

Misys Opics Risk Plus and Misys Eagleye provide a comprehensive risk
management framework for the central bank including performance and return
attribution analysis, portfolio and currency compliance limits and policy
controls. The integrated front-to-back system will provide for easier
reconciliation and regulatory reporting.

Mr Loi Martin Bakani, Governor, Bank of Papua New Guinea, said: "We were
keen to modernise our infrastructure in order to gain greater transparency,
operational efficiency and risk management across our reserves management
operations. Misys was the ideal partner due to its leading solutions and
excellent track record in delivering leading treasury systems."

Mr. Lee Boon Huat, Asia Pacific Managing Director of Misys adds: "Bank of
Papua New Guinea plays an important role in managing the local economy and in
facilitating effective trade and payments, both at a national level and
internationally. With our strong track record in treasury solutions, Misys
was able to demonstrate that it is the leading provider to help modernise the
reserves management operations of the Bank. This is an exciting partnership
for Misys and we look forward to helping the team at Bank of Papua New Guinea
take advantage of our leading technology to bring greater efficiency and
stability to the country's economy."

Misys Solutions for Treasury & Capital Markets has 31 years of experience
and unrivalled software development expertise. It creates integrated,
comprehensive solutions for financial institutions to manage their capital
market activities across multiple asset classes.

About Misys plc

Misys plc (LSE: MSY), provides integrated, comprehensive solutions that
deliver significant results to organisations in the financial services and
healthcare industries. We maximise value for our customers by combining our
deep knowledge of their business with our commitment to their success.

In banking and treasury & capital markets, Misys is a market leader, with
over 1,200 customers, including all of the world's top 50 banks. In
healthcare, Misys plc owns a controlling stake in NASDAQ-listed
Allscripts-Misys Healthcare Solutions, Inc, a clear leader in the provision
of healthcare technology, serving more than 150,000 physicians, 700 hospitals
and nearly 7,000 post-acute and homecare organisations. Misys employs around
6,000 people who serve customers in more than 120 countries.

We aspire to be the world's best application software and services
company, delivering results for the most important industries in the world.

Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished.Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.Full Disclaimer